Market Overview:
The global contract bio-manufacturing organization (CMO) market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing demand for biologics and rising number of biotechnology and pharmaceutical companies outsourcing their manufacturing needs to contract manufacturers. Based on type, the global CMO market can be segmented into big bio/pharma type, small/med bio/pharma type, and virtual/emerging type. The big bio/pharma type segment is expected to account for the largest share of the global CMO market in 2018. This segment is projected to grow at a CAGR of 7.8% from 2018 to 2030 due to the increasing demand for complex biologics products such as monoclonal antibodies (mAbs), recombinant proteins, and vaccines. On the basis of application, the global CMO market can be divided into pharmaceutical industry, biotechnology industry, and other applications segments such as medical devices and diagnostics). The pharmaceutical industry segment accounted for majority share of 43% in 2017 owing high product demand coupled with stringent regulatory norms across developed countries including UAS., Europe., Japan., Canada., etcetera Furthermore,. this sector will continue its dominance during forecast period owning highest Compound Annual Growth Rate (CAGR) over 8%.
 Industry Outlook.svg)
Product Definition:
A contract bio-manufacturing organization (CMO) is a company that specializes in the manufacturing of biologic drugs. These companies typically have expertise in areas such as cell culture, protein purification, and lyophilization. They are often used by biotechnology and pharmaceutical companies to manufacture large quantities of their products for clinical trials or commercial sale.
Big Bio/Pharma Type:
The global big pharma/bio type is expected to grow at a lucrative rate over the forecast period. The growth of this market can be attributed to factors such as increasing R&D investments by large pharmaceutical companies, rising healthcare expenditure and growing demand for biologics across the globe. Big pharma/bio types are used in CMOs for commercial production of biopharmaceuticals which are made using recombinant DNA technology.
Small/Med Bio/Pharma Type:
Small/med bio/pharma type is used by CMOs to procure biopharmaceutical products at a low cost. The number of small molecules and biotech companies has been increasing rapidly over the past few years, which has led to an increase in demand for these products. Small or med bio or pharma type contract manufacturing services are provided for product development & pre-clinical stage biopharmaceuticals till commercialization.
Application Insights:
The pharmaceutical industry was the dominant application segment in 2017 and is expected to continue its dominance over the forecast period. The growth of this industry can be attributed to factors such as increasing geriatric population, prevalence of chronic diseases, and growing demand for high-quality drugs.
The biotechnology segment is also expected to grow rapidly owing to increasing investments by companies in R&D activities related to bio-production of various products including vaccines, enzymes replacements & inhibitors, cell therapies & gene therapies. Other applications include food & beverages and cosmetics industries.
Regional Analysis:
North America dominated the global contract bio-manufacturing organization market in 2017. This is due to presence of a large number of CMOs and increasing outsourcing activities in this region. In addition, growing focus on compliance with cGMPs and FDA regulations by Big Pharma companies is driving the regional market growth. Asia Pacific is expected to witness lucrative growth over the forecast period owing to presence of emerging as well as developed countries such as Japan, China, India among others which are majorly responsible for product demand in this region.
Growth Factors:
- Increasing demand for biologics and biosimilars: The global market for biologics is expected to grow at a CAGR of over 10% from 2016 to 2020. This is primarily due to the increasing prevalence of chronic diseases, rising awareness about available treatments, and the advent of novel therapies. The market for biosimilars is also expected to grow rapidly in the next few years as more countries adopt these drugs as an affordable alternative to branded biologics. Contract bio-manufacturing organizations are well-positioned to capitalize on this growth by providing high-quality manufacturing services at competitive prices.
- Growing focus on personalized medicine: A major trend in the pharmaceutical industry today is personalized medicine, which involves developing therapies that are tailored specifically for individual patients based on their genetic makeup or disease profile. Contract bio-manufacturing organizations can play a key role in helping pharmaceutical companies bring such therapies to market by providing customized manufacturing services that meet the specific needs of each product candidate.
- Advances in gene therapy: Gene therapy is an exciting new field that holds great potential for treating a variety of diseases including cancer, heart disease, and diabetes. Contract bio-manufacturing organizations have been quick to embrace this technology and are now well positioned to help commercialize gene therapy products worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Contract Bio-manufacturing Organization(CMO) Market Research Report
By Type
Big Bio/Pharma Type, Small/Med Bio/Pharma Type, Virtual/Emerging Type
By Application
Pharmaceutical Industry, Biotechnology, Other
By Companies
Abzena, Althea, Asymchem Laboratories Inc., Baxter Biopharma Solutions, Biomeva, Boehringer Ingelheim, Celltrion, AGC Biologics, Cytovance Biologics, Fujifilm Diosynth Technologies, KBI Biopharma, Lonza Group, MicroProtein Technologies, Patheon, Porton Pharma Solutions, Probiogen, Rader, Rentschler Biotechnologie, Samsung, Sandoz, STA Pharmaceutical Co. Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
203
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Contract Bio-manufacturing Organization(CMO) Market Report Segments:
The global Contract Bio-manufacturing Organization(CMO) market is segmented on the basis of:
Types
Big Bio/Pharma Type, Small/Med Bio/Pharma Type, Virtual/Emerging Type
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Industry, Biotechnology, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abzena
- Althea
- Asymchem Laboratories Inc.
- Baxter Biopharma Solutions
- Biomeva
- Boehringer Ingelheim
- Celltrion
- AGC Biologics
- Cytovance Biologics
- Fujifilm Diosynth Technologies
- KBI Biopharma
- Lonza Group
- MicroProtein Technologies
- Patheon
- Porton Pharma Solutions
- Probiogen
- Rader
- Rentschler Biotechnologie
- Samsung
- Sandoz
- STA Pharmaceutical Co. Ltd
 Market Overview.svg)
Highlights of The Contract Bio-manufacturing Organization(CMO) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Big Bio/Pharma Type
- Small/Med Bio/Pharma Type
- Virtual/Emerging Type
- By Application:
- Pharmaceutical Industry
- Biotechnology
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Contract Bio-manufacturing Organization(CMO) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A Contract Bio-manufacturing Organization (CMO) is a business model that involves contracting with third-party manufacturers to produce products using biotechnology. CMOs can provide customers with access to high-quality, affordable products while freeing up the company's own resources to focus on other strategic initiatives.
Some of the major companies in the contract bio-manufacturing organization(cmo) market are Abzena, Althea, Asymchem Laboratories Inc., Baxter Biopharma Solutions, Biomeva, Boehringer Ingelheim, Celltrion, AGC Biologics, Cytovance Biologics, Fujifilm Diosynth Technologies, KBI Biopharma, Lonza Group, MicroProtein Technologies, Patheon, Porton Pharma Solutions, Probiogen, Rader, Rentschler Biotechnologie, Samsung, Sandoz, STA Pharmaceutical Co. Ltd.
The contract bio-manufacturing organization(cmo) market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Contract Bio-manufacturing Organization(CMO) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Contract Bio-manufacturing Organization(CMO) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Contract Bio-manufacturing Organization(CMO) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Contract Bio-manufacturing Organization(CMO) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Contract Bio-manufacturing Organization(CMO) Market Size & Forecast, 2018-2028
4.5.1 Contract Bio-manufacturing Organization(CMO) Market Size and Y-o-Y Growth
4.5.2 Contract Bio-manufacturing Organization(CMO) Market Absolute $ Opportunity
Chapter 5 Global Contract Bio-manufacturing Organization(CMO) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Type
5.2.1 Big Bio/Pharma Type
5.2.2 Small/Med Bio/Pharma Type
5.2.3 Virtual/Emerging Type
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Contract Bio-manufacturing Organization(CMO) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Applications
6.2.1 Pharmaceutical Industry
6.2.2 Biotechnology
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Contract Bio-manufacturing Organization(CMO) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Contract Bio-manufacturing Organization(CMO) Analysis and Forecast
9.1 Introduction
9.2 North America Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Type
9.6.1 Big Bio/Pharma Type
9.6.2 Small/Med Bio/Pharma Type
9.6.3 Virtual/Emerging Type
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Applications
9.10.1 Pharmaceutical Industry
9.10.2 Biotechnology
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Contract Bio-manufacturing Organization(CMO) Analysis and Forecast
10.1 Introduction
10.2 Europe Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Type
10.6.1 Big Bio/Pharma Type
10.6.2 Small/Med Bio/Pharma Type
10.6.3 Virtual/Emerging Type
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Applications
10.10.1 Pharmaceutical Industry
10.10.2 Biotechnology
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Contract Bio-manufacturing Organization(CMO) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Type
11.6.1 Big Bio/Pharma Type
11.6.2 Small/Med Bio/Pharma Type
11.6.3 Virtual/Emerging Type
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Applications
11.10.1 Pharmaceutical Industry
11.10.2 Biotechnology
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Contract Bio-manufacturing Organization(CMO) Analysis and Forecast
12.1 Introduction
12.2 Latin America Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Type
12.6.1 Big Bio/Pharma Type
12.6.2 Small/Med Bio/Pharma Type
12.6.3 Virtual/Emerging Type
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Applications
12.10.1 Pharmaceutical Industry
12.10.2 Biotechnology
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Contract Bio-manufacturing Organization(CMO) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Type
13.6.1 Big Bio/Pharma Type
13.6.2 Small/Med Bio/Pharma Type
13.6.3 Virtual/Emerging Type
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Contract Bio-manufacturing Organization(CMO) Market Size Forecast by Applications
13.10.1 Pharmaceutical Industry
13.10.2 Biotechnology
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Contract Bio-manufacturing Organization(CMO) Market: Competitive Dashboard
14.2 Global Contract Bio-manufacturing Organization(CMO) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abzena
14.3.2 Althea
14.3.3 Asymchem Laboratories Inc.
14.3.4 Baxter Biopharma Solutions
14.3.5 Biomeva
14.3.6 Boehringer Ingelheim
14.3.7 Celltrion
14.3.8 AGC Biologics
14.3.9 Cytovance Biologics
14.3.10 Fujifilm Diosynth Technologies
14.3.11 KBI Biopharma
14.3.12 Lonza Group
14.3.13 MicroProtein Technologies
14.3.14 Patheon
14.3.15 Porton Pharma Solutions
14.3.16 Probiogen
14.3.17 Rader
14.3.18 Rentschler Biotechnologie
14.3.19 Samsung
14.3.20 Sandoz
14.3.21 STA Pharmaceutical Co. Ltd
